drugset / Trial / NCT03388450

Omega-3 Fatty Acid for Critically Ill Patients.

NCT03388450

Completed 110 enrolled Menoufia University
RandomizedCrossoverQuadruple-blindOther

Summary

Sepsis is the most common reason for intensive care unit (ICU) admission. Sepsis flares up the systemic inflammatory response with its mediators. Sepsis treatment protocols have been established in many centres with immune nutrient as adjuvant treatment. Omega-3 fatty acid and other anti-oxidants formulae have been found to improve sepsis outcome. In most of the studies, immune nutrients were giving parenterally, however, nowadays the preferable route of feeding in critically ill patients is enterally. The present study was done to investigate the effect of enteral Omega-3 fatty acid in septic critically ill patients.

Timeline

Start
2015-01-15
Primary completion
2017-10-27
Completion
2017-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omega-3 fatty acids Unknown 1000 mg Other